Sphingosine 1-phosphate inhibits ischemia reperfusion injury following experimental lung transplantation

Keyphrases

• Ischemia-reperfusion Injury 100%
• Experimental Lung Transplantation 100%
• Sphingosine-1-phosphate 100%
• Endothelial Cells 33%
• Reperfusion 33%
• Lung Transplantation 33%
• Pulmonary Edema 33%
• Interleukin-1β 16%
• Dysregulated 16%
• Transplantation 16%
• Neutrophils 16%
• MIP-2 16%
• Rat Lung 16%
• Lung Tissue 16%
• Inflammation 16%
• Infiltration 16%
• Inflammatory Pathways 16%
• Syngeneic 16%
• Receptor Agonist 16%
• Oxygenation 16%
• Graft Function 16%
• Pulmonary Function 16%
• Lymphocyte Activation 16%
• Tissue Homeostasis 16%
• Monocytic 16%
• Endothelial Barrier Function 16%
• Endothelial Barrier 16%
• Activated Lymphocytes 16%
• Junction Formation 16%
• Leukocyte Chemotaxis 16%
• Signaling Pathway Activation 16%
• G-coupled Protein Receptors 16%
• Cell Tight Junction 16%
• Phosphate Treatment 16%

Immunology and Microbiology

• Lung Transplantation 100%
• Reperfusion 100%
• Homeostasis 20%
• Tumor Necrosis Factor 20%
• Interleukin 1 20%
• Syngenic 20%
• Agonist 20%
• Neutrophil 20%
• Chemotaxis 20%
• Lung Function 20%
• Tight Junction 20%
• Oxygenation 20%
• Lymphocyte Migration 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Reperfusion Injury 100%
• Sphingosine 1 Phosphate 100%
• Lung Edema 33%
• Tumor Necrosis Factor 16%
• Inflammation 16%
• Interleukin 1 16%
• Receptor Agonist 16%